Waters Launches BD FACSDiscover A7 Cell Analyzer to Standardize Spectral Flow Cytometry
Event summary
- Waters Corporation launched the BD FACSDiscover A7 Cell Analyzer globally on September 14, 2026.
- The analyzer combines BD SpectralFX Technology with FACSTruQ Technology for industry-leading standardization.
- The device supports up to 50+ parameter experiments with less than 10% coefficient of variation across dyes.
- The analyzer is priced to make advanced spectral flow cytometry more accessible to researchers.
The big picture
Waters' launch of the BD FACSDiscover A7 Cell Analyzer addresses the growing need for standardization in flow cytometry, a critical tool in cancer and disease research. The device's ability to minimize instrument and user differences could set a new industry benchmark, potentially reshaping how labs approach high-parameter experiments. This move aligns with broader trends in life sciences towards greater reproducibility and data consistency.
What we're watching
- Adoption Pace
- How quickly academic and pharmaceutical labs will integrate the A7 Cell Analyzer into their workflows.
- Competitive Response
- Whether competitors will introduce similar standardization technologies to challenge Waters' lead.
- Revenue Impact
- The contribution of the A7 Cell Analyzer to Waters' Biosciences division revenue growth.
Related topics